Serum ficolin-2 in hospitalised patients with community-acquired pneumonia

James D Chalmers1, Gilly B Fleming, Julia Rutherford

  • 1Tayside Respiratory Research Group, University of Dundee, Dundee, UK, jchalmers@dundee.ac.uk.

Inflammation
|April 17, 2014
PubMed

Insights

Serum levels of mannose binding lectin (MBL) and ficolin-2 were not linked to community-acquired pneumonia (CAP) susceptibility or outcomes in this study. Further research into ficolin-2 in severe CAP is warranted.

Area of Science:

  • Immunology
  • Complement System
  • Infectious Diseases

Background:

  • Mannose binding lectin (MBL) and ficolins are key components of the lectin pathway in complement-mediated host defense.
  • Community-acquired pneumonia (CAP) is a significant global health concern, and understanding host factors influencing its severity is crucial.

Purpose of the Study:

  • To investigate the association between serum levels of MBL and ficolin-2 and the susceptibility and outcomes of CAP.
  • To determine if MBL deficiency or ficolin-2 insufficiency impacts mortality, mechanical ventilation, vasopressor support, or complications in CAP patients.

Main Methods:

  • Serum levels of MBL and ficolin-2 were measured in 276 patients with CAP.
  • MBL deficiency and ficolin-2 insufficiency were defined using established cut-off values.
  • Outcomes including 30-day mortality, mechanical ventilation/vasopressor support, and composite outcomes were analyzed in relation to MBL and ficolin-2 levels.

Main Results:

  • No significant differences in MBL or ficolin-2 levels were observed between CAP patients and controls.
  • MBL-deficient patients did not show an increased risk of 30-day mortality or a composite outcome.
  • Very low ficolin-2 levels showed a trend towards association with adverse outcomes, but did not reach statistical significance.

Conclusions:

  • Low serum levels of MBL and ficolin-2 are not associated with increased susceptibility to CAP.
  • While not statistically significant, very low ficolin-2 levels may be associated with poorer outcomes in CAP.
  • Further investigation into ficolin-2's role as a potential modifier of CAP severity, particularly in severe cases, is justified.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.7K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.2K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
749
Sputum Studies II: Culture and Sensitivity01:20

Sputum Studies II: Culture and Sensitivity

Description
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
2.0K